Fulcrum Therapeutics, Inc.·4

Dec 9, 4:30 PM ET

Banks Sonja 4

4 · Fulcrum Therapeutics, Inc. · Filed Dec 9, 2021

Insider Transaction Report

Form 4
Period: 2021-12-08
Banks Sonja
Director
Transactions
  • Award

    Stock Option (right to buy)

    2021-12-08+30,00030,000 total
    Exercise: $15.73Exp: 2031-12-07Common Stock (30,000 underlying)
Footnotes (1)
  • [F1]This option was granted on December 8, 2021 and is scheduled to vest in equal monthly installments until December 8, 2024, subject to continued service.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION